Clinical Trial Update: FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating FOLFOX4 in combination with Endostar for advanced colorectal cancer; the update provides no results or status details.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)
• FOLFOX4 (Folinic acid (Leucovorin), Fluorouracil (5-FU), Oxaliplatin)

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Colorectal Neoplasms | Phase 2 | Status: UNKNOWN